Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
about
BMP2 and mechanical loading cooperatively regulate immediate early signalling events in the BMP pathwayElectromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effectsCyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscleLuteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in miceSoluble guanylate cyclase as a novel treatment target for osteoporosis.PKG II inhibits EGF/EGFR-induced migration of gastric cancer cellsCyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts.Stepwise increasing and decreasing fluid shear stresses differentially regulate the functions of osteoblastsBioprocess forces and their impact on cell behavior: implications for bone regeneration therapy.Pro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and IIType II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.Mechanical regulation of signaling pathways in bone.Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransductionLocal delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.Structural Basis of Cyclic Nucleotide Selectivity in cGMP-dependent Protein Kinase IIRole of Epithelium Sodium Channel in Bone Formation.Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.Role of the ER/NO/cGMP Signaling Pathway in the Promotion of Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Actaea racemosa Extract.Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D/bioreactor model.cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.cGMP becomes a drug target.Heart failure as a risk factor for osteoporosis and fractures.cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.Nitric oxide signaling in mechanical adaptation of bone.The biology of distraction osteogenesis for correction of mandibular and craniomaxillofacial defects: A review.Ferulic acid induces proliferation and differentiation of rat osteoblasts in vitro through cGMP/PKGII/ENaC signaling.The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation.Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway.Natriuretic peptide activation of extracellular regulated kinase 1/2 (ERK1/2) pathway by particulate guanylyl cyclases in GH3 somatolactotropes.Fluid shear stress and melatonin in combination activate anabolic proteins in MC3T3-E1 osteoblast cells.Primary gene response to mechanical loading in healing rat Achilles tendons.Src activation by cGMP/PKG II in osteoblasts: characterization of a mechano-sensitive signalling complex.Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor.A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.Fos Promotes Early Stage Teno-Lineage Differentiation of Tendon Stem/Progenitor Cells in Tendon.Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.Epithelial sodium channel enhanced osteogenesis via cGMP/PKGII/ENaC signaling in rat osteoblast.Structural basis of cyclic nucleotide selectivity in cGMP dependent protein kinase II.
P2860
Q24317657-77EC159E-5EE1-40E1-9825-D35E07870ECDQ26858920-D40D81CE-6E5F-45ED-BE99-32C97DC6E4EEQ27329655-2848AEA3-7A82-4D8F-8023-547760847A76Q33717115-0425926B-67B9-4213-83A2-E0A10AC0A5EFQ34551704-5B8F8104-59E2-43E5-8EC2-D1521FE7DD29Q34684803-0FEB185E-C2FC-42A2-A907-6ECFEFAB869AQ34977213-289340D6-2721-40C5-A7BF-BEA6A8DB12E3Q34989469-C7096D18-A214-4DF2-BCE4-4DBD906220CFQ35195102-03DC9ADC-E120-46A1-B6C0-69531732A5F7Q35668850-DE64B208-2122-4587-BA0D-7E75CAB2DC7CQ35758953-4F297BDF-F59A-47CF-A612-E167651365C4Q36019769-8A7C1EF8-0F3A-40CC-9615-BA834369FF23Q36033313-29DE9E30-E3AB-40AF-BC3B-FAA9731423D3Q36060627-C87FE758-0EB0-4D6D-94BB-7C19B27C852CQ36674623-D86D203C-8C52-4BDA-9A25-A1A98A827A25Q36720098-2D69B8BE-04B4-4465-9601-C28B63BFB9EEQ37327723-822450D4-0BA8-4773-B6C4-400B447D7DC2Q37448013-283FB5FB-9441-4A1C-99C3-8B465466FCC1Q37448608-EA14ADCD-DE4F-4255-9E13-561FA4876DE7Q37690613-AC43BA3A-08FF-4E2C-9AA6-23F7E279020FQ37855854-C4B125A4-77D2-4C62-8FB2-7685F2CFE71EQ37980659-D67B0A90-7DEF-43D0-B27B-5C3C17F4EFE9Q38036949-D710B185-6A53-4449-8711-D823BB576026Q38166201-07BCCEC3-FE9B-4050-9465-7368E2AB030BQ38169910-004DBDC3-9783-4B6E-939A-65DD9FDB536CQ38201014-DBEE9253-74B9-483E-B7BE-46821916D511Q38289600-193F3640-CCA2-4484-8651-74598DDE081CQ39083425-9D3DCDE9-B8C1-40BB-ADD1-14D7FCC8634EQ41358345-D5ACD2FF-82EB-4D6B-B3B2-F2757500836BQ41581124-023F4E62-B628-4A56-8C91-756A9B2F470BQ42825651-9888FCEA-FFCD-45C5-B8E1-90DD6F4BC0A6Q43831222-19AD78A0-6B0A-4B82-B0D4-53999F400163Q45928385-00CA6F81-BC79-45B0-9FF2-D47C019C30EEQ46551375-A794599B-B95F-4D91-9AD8-3A0F8FD92D6EQ46907891-E1742FAA-BFA5-4BBF-83B1-89EFC0CA30A0Q47901114-60621D4D-920B-4AAB-BF46-718131C633FDQ49699560-0AA2FC0F-F37D-42DF-9FBD-3CA334F81317Q54117757-7A40B5E2-6B4A-49C4-8E10-1DF97E965528Q54380855-F33B4805-8177-404A-8D24-B0202F00ADE4Q54924479-8559D45F-96AD-4738-9DEC-ACB192C7E26C
P2860
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@en
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@nl
type
label
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@en
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@nl
prefLabel
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@en
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@nl
P2093
P2860
P356
P1476
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.
@en
P2093
Gerry R Boss
Hema Rangaswami
Jiunn-Chern Yeh
John A Frangos
Nisha Marathe
Renate B Pilz
Shunhui Zhuang
Yongchang Chen
P2860
P304
14796-14808
P356
10.1074/JBC.M806486200
P407
P577
2009-03-11T00:00:00Z